18265-Lymphomas-NA-1270

Lymphomas

(MO40597) A MULTICENTRIC, OPEN-LABEL, SINGLE ARM STUDY OF OBINUTUZUMAB SHORT DURATION INFUSION (SDI) IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED FOLLICULAR LYMPHOMA (PHASE IV STUDY)

  • Details

ClinicalTrials.gov ID: NCT03817853
Diagnosis Type: NA
USOR Number: 18265

  • Address

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, CO 80228
P: (303) 430-2700

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.